Delivery Order SPE2DB22D1106-SPE2DB24FEMM2
Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $4.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA). The contract has an award value of $15,211.03 and an ultimate completion date of January 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,020.20 and is a Firm Fixed Price Delivery Order, with a period of performance ending on February 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA). The contract, valued at $2,265.22, is a delivery order with a firm fixed price. The award date is October 8, 2024, and the ultimate completion date is October 9, 2024. This contract is not a set-aside. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts by...
- This federal contract award is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA). The contract, valued at $8,010.84, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 24, 2024. The contract was awarded on January 23, 2024 and does not have a set-aside designation, indicating it was awarded...
- This contract award is for the delivery of 4564560206 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $2,612.81 and is a Firm Fixed Price Delivery Order contract with a completion date of May 10, 2024. The contract does not have a set-aside...
- This federal contract award is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a generic pharmaceutical product, to the Defense Logistics Agency (DLA). The award, with a ceiling value of $8,323.95, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of 1,000 units of the pharmaceutical product Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA). The $3,215.30 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corporation's Corporate Office division, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565214153 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price of $1,062.78 and an ultimate completion date of July 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The federal contract award details a delivery order for TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) with a total ceiling value of $8,955.62. The contract has a firm fixed-price pricing type and a period of performance ending on March 12, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of 4,563,310,435 units of Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA), which is a defense agency. The contract was awarded on January 11, 2024, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $1,541.82. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 12, 2024. The contract does not have a set-aside designation, indicating open...